Annual Operating Expenses
$8.32 M
+$769.00 K+10.19%
31 December 2023
Summary:
Intensity Therapeutics Common stock annual total operating expenses is currently $8.32 million, with the most recent change of +$769.00 thousand (+10.19%) on 31 December 2023. During the last 3 years, it has risen by +$322.50 thousand (+4.03%). INTS annual operating expenses is now at all-time high.INTS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$3.57 M
-$1.50 M-29.57%
30 September 2024
Summary:
Intensity Therapeutics Common stock quarterly total operating expenses is currently $3.57 million, with the most recent change of -$1.50 million (-29.57%) on 30 September 2024. Over the past year, it has increased by +$218.00 thousand (+6.50%). INTS quarterly operating expenses is now -29.57% below its all-time high of $5.07 million, reached on 30 June 2024.INTS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INTS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +6.5% |
| 3 y3 years | +4.0% | +49.2% |
| 5 y5 years | +46.6% | - |
INTS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +10.2% | -29.6% | +192.4% |
| 5 y | 5 years | at high | +46.6% | -29.6% | +192.4% |
| alltime | all time | at high | +46.6% | -29.6% | +192.4% |
Intensity Therapeutics Common Stock Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.57 M(-29.6%) |
| June 2024 | - | $5.07 M(+6.9%) |
| Mar 2024 | - | $4.74 M(+41.5%) |
| Dec 2023 | $8.32 M(+10.2%) | $3.35 M(+34.6%) |
| Sept 2023 | - | $2.49 M(+104.0%) |
| June 2023 | - | $1.22 M(-2.6%) |
| Mar 2023 | - | $1.25 M(-14.9%) |
| Dec 2022 | $7.55 M | $1.47 M(-16.6%) |
| Sept 2022 | - | $1.77 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $1.93 M(-18.9%) |
| Mar 2022 | - | $2.38 M(-0.6%) |
| Dec 2021 | $8.00 M(+28.5%) | - |
| Dec 2021 | - | $2.39 M(+11.9%) |
| Sept 2021 | - | $2.14 M(+8.8%) |
| June 2021 | - | $1.96 M(+30.9%) |
| Mar 2021 | - | $1.50 M(-9.4%) |
| Dec 2020 | $6.22 M(+9.7%) | $1.66 M |
| Dec 2019 | $5.68 M | - |
FAQ
- What is Intensity Therapeutics Common stock annual total operating expenses?
- What is the all time high annual operating expenses for Intensity Therapeutics Common stock?
- What is Intensity Therapeutics Common stock quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Intensity Therapeutics Common stock?
- What is Intensity Therapeutics Common stock quarterly operating expenses year-on-year change?
What is Intensity Therapeutics Common stock annual total operating expenses?
The current annual operating expenses of INTS is $8.32 M
What is the all time high annual operating expenses for Intensity Therapeutics Common stock?
Intensity Therapeutics Common stock all-time high annual total operating expenses is $8.32 M
What is Intensity Therapeutics Common stock quarterly total operating expenses?
The current quarterly operating expenses of INTS is $3.57 M
What is the all time high quarterly operating expenses for Intensity Therapeutics Common stock?
Intensity Therapeutics Common stock all-time high quarterly total operating expenses is $5.07 M
What is Intensity Therapeutics Common stock quarterly operating expenses year-on-year change?
Over the past year, INTS quarterly total operating expenses has changed by +$218.00 K (+6.50%)